Lecture at iCA PhD Program
On 28 June 2022, our CEO Dr. Thomas Frischmuth gave the lecture “Strategies to control COVID-19 pandemic and disease – nucleic acids-based vaccines and drugs” as part of a midterm workshop on the PhD program iCA. To Dr. Frischmuth it was important to present the further development of drug candidates for clinical research and clinical application. For doctoral students, this was an opportunity to visualize the potential that research results from the laboratory can have for clinical application.
The PhD program iCA works on new anti-infectives, based on innovative digital techniques, which are brought in through cooperation between the Technical University of Braunschweig, Helmholtz Center for Infection Research and Ostfalia University. Through the extensive use of digital technologies (especially from chemical and bioinforma tics and theoretical chemistry) in all sub-areas of the doctoral program, a significant added value will be achieved, which should enable significant medical advances in the treatment of infectious diseases in the future.
Doctoral students deal with projects ranging from the identification of new targets as a target for pharmaceuticals to machine learning methods for the evaluation of metabolic data. The program is about using digitization methods to identify new active ingredients and new biological target structures more quickly.